Ray Dalio’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Buy |
253,811
+182,515
| +256% | +$15.9M | 0.09% | 169 |
|
|
2025
Q1 | $4.87M | Sell |
71,296
-26,642
| -27% | -$1.82M | 0.02% | 361 |
|
|
2024
Q4 | $7.62M | Sell |
97,938
-221,691
| -69% | -$17.2M | 0.03% | 289 |
|
|
2024
Q3 | $21.4M | Sell |
319,629
-27,695
| -8% | -$1.86M | 0.12% | 148 |
|
|
2024
Q2 | $39.4M | Sell |
347,324
-23,540
| -6% | -$2.67M | 0.21% | 81 |
|
|
2024
Q1 | $51.4M | Sell |
370,864
-62,291
| -14% | -$8.64M | 0.26% | 72 |
|
|
2023
Q4 | $53.8M | Sell |
433,155
-168,208
| -28% | -$20.9M | 0.3% | 66 |
|
|
2023
Q3 | $56.1M | Buy |
601,363
+183,141
| +44% | +$17.1M | 0.34% | 57 |
|
|
2023
Q2 | $53.7M | Sell |
418,222
-37,149
| -8% | -$4.77M | 0.33% | 64 |
|
|
2023
Q1 | $52.9M | Buy |
455,371
+23,847
| +6% | +$2.77M | 0.32% | 63 |
|
|
2022
Q4 | $48.9M | Sell |
431,524
-191,759
| -31% | -$21.7M | 0.27% | 79 |
|
|
2022
Q3 | $50.2M | Sell |
623,283
-9,771
| -2% | -$787K | 0.25% | 79 |
|
|
2022
Q2 | $47.2M | Buy |
633,054
+487,813
| +336% | +$36.4M | 0.2% | 104 |
|
|
2022
Q1 | $74.3M | Buy |
145,241
+38,707
| +36% | +$19.8M | 0.3% | 60 |
|
|
2021
Q4 | $57.2M | Buy |
106,534
+12,281
| +13% | +$6.59M | 0.33% | 51 |
|
|
2021
Q3 | $51.5M | Sell |
94,253
-11,159
| -11% | -$6.1M | 0.28% | 69 |
|
|
2021
Q2 | $45M | Buy |
105,412
+68,880
| +189% | +$29.4M | 0.29% | 67 |
|
|
2021
Q1 | $13.1M | Buy |
36,532
+4,008
| +12% | +$1.44M | 0.12% | 139 |
|
|
2020
Q4 | $12M | Buy |
32,524
+15,105
| +87% | +$5.58M | 0.1% | 107 |
|
|
2020
Q3 | $7.18M | Buy |
+17,419
| New | +$7.18M | 0.09% | 105 |
|